Identify potential risks, inconsistencies, and red flags across all tender documents. Get a detailed risk report with severity levels and mitigation recommendations.
LoginGet an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.
LoginUpgrade to see which companies are likely to bid on this tender, based on historical procurement data.
Login9 requirements across 5 categories
Sign up to view complete requirements and analysis
Get AI-generated summaries of all tender documents. Quickly understand what each document contains without reading hundreds of pages — covering scope, conditions, evaluation criteria, and key obligations.
LoginThis tender is generally well-structured with a clear description and substantial estimated value, but lacks specific details on evaluation criteria and technical/financial requirements.
The tender follows an open procedure and specifies a CPV code for pharmaceutical products. Deadlines appear reasonable given the active status and submission date. No disputes are noted. The procedure is described as 'competition' which is a bit vague but acceptable. Regulatory compliance is assumed unless otherwise indicated.
The description of Amgros I/S and its purpose is clear. The nature of the framework agreements (non-exclusive, no purchase obligation) is well-defined. However, the absence of specified evaluation criteria and detailed technical/financial requirements reduces overall clarity.
Basic information such as title, reference, organization, estimated value, and deadline are present. Two tender documents are indicated. However, crucial details like contract duration, specific technical and financial requirements, and the content of the attached documents are not fully accessible or detailed in the provided summary.
The tender is an open procedure, and the framework agreements are non-exclusive, promoting broad participation. The estimated value is disclosed. The lack of specific tailored requirements for particular companies suggests good fairness. However, the absence of detailed evaluation criteria could be a concern for bidders.
The tender is marked as 'E-Procurement', suggesting electronic submission is possible. However, the 'Issues' section notes 'No e-submission', which is contradictory and a significant concern. The contract start date is not specified, and financing information is absent. The duration of the contract is also missing.
Key fields like title, reference, organization, value, and deadline are populated. There are no reported suspensions or disputes. Dates are logical, with the submission deadline well into the future from the publication date. The 'active' status is consistent with an upcoming deadline.
There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. This suggests a lack of focus on these areas.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Our procurement experts prepare everything. Proven to work — you review, approve, and submit.
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required